Pneumologie 2025; 79(S 01): S94-S95
DOI: 10.1055/s-0045-1804751
DOI: 10.1055/s-0045-1804751
Abstracts
D1 – Infektiologie und Tuberkulose
Subgruppenanalyse der jahrlichen Exazerbationsrate bei Patientinnen und Patienten mit Bronchiektasen-Erkrankung ohne Cystische Fibrose in der randomisierten, doppleblinden, placebokontrollierten Phase-3-Studie ASPEN
Authors
-
F Ringshausen
1 Medizinische Hochschule Hannover (Mhh); Klinik für Pneumologie und Infektiologie -
P Burgel
2 Hôpital Cochin and Cystic Fibrosis National Reference Center; Service de Pneumologie, Ap-Hp and Université Paris Cité -
C Daley
3 National Jewish Health und University of Colorado -
A De Soyza
4 Population and Health Sciences Institute, Nihr Biomedical Research Centre for Aging; Newcastle University und Department of Respiratory Medicine; Newcastle Upon Tyne NHS Foundation Trust -
C Haworth
5 Royal Papworth Hospital NHS Foundation Trust; Cambridge Centre for Lung Infection -
D Mauger
6 Pennsylvania State University -
M Loebinger
7 Royal Brompton and Harefield NHS Foundation Trust; Host Defence Unit; Imperial College London -
T Aksamit
8 Mayo Clinic; Pulmonary Disease and Critical Care Medicine -
N Hasegawa
9 Keio University School of Medicine -
K Morimoto
10 Fukujūji Hospital; Japan Anti-Tuberculosis Association -
M Metersky
11 University of Connecticut School of Medicine -
K Mange
12 Insmed Incorporated -
A Teper
13 Insmed Incorporate -
C Fernandez
12 Insmed Incorporated -
C Fan
12 Insmed Incorporated -
X Zhang
12 Insmed Incorporated -
J Chalmers
14 University of Dundee; College of Life Sciences; Lecturer in Respiratory Medicine
